Amgen (AMGN) Shares Outstanding (Weighted Average) (2009 - 2026)

Amgen's Shares Outstanding (Weighted Average) history runs 18 years deep, the most recent figure standing at $540.0 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) changed 0.37% year-over-year to $540.0 million; the TTM figure through Mar 2026 stood at $540.0 million (changed 0.37% YoY), while the FY2025 annual figure was $538.0 million, changed 0.19% from the prior year.
• Shares Outstanding (Weighted Average) was $540.0 million for Q1 2026 at Amgen, roughly flat from $538.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $548.0 million in Q1 2022 to a low of $534.0 million in Q1 2023.
• Historically, Shares Outstanding (Weighted Average) has averaged $537.5 million across 5 years, with a median of $537.0 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Weighted Average) declined 6.63% in 2022, then grew 0.37% in 2024.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $538.0 million in 2022, then slipped by 0.56% to $535.0 million in 2023, then increased by 0.37% to $537.0 million in 2024, then rose by 0.19% to $538.0 million in 2025, then climbed by 0.37% to $540.0 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $540.0 million (Q1 2026), $538.0 million (Q4 2025), and $538.0 million (Q3 2025), per Business Quant data.